Increased risk of familial late-onset Alzheimer's disease in women

Neurology

Volumn 46, Issue 1, 1996, Pages 126-129

  Payami, H ^a,b   Montee, K ^a   Grimslid, H ^a   Shattuc, S ^a   Kaye, J ^b,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; HUMAN; MALE; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE;

EID: 0030004358     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.1.126     Document Type: Article

References (30)

1. Bachman DL, Wolf PA, Linn R, et al. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology 1992;42:115-119.
2. Rocca WA, Hofman A, Brayne C, et al. Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence findings. Ann Neurol 1991;30:381-390.
3. Aronson MK, Ooi WL, Morgenstern H, et al. Women, myocardial infarction, and dementia in the very old. Neurology 1990; 40:1102-1106.
4. Katzman R. Alzheimer disease. New York: Raven Press, 1994.
5. Bachman DL, Wolf PA, Linn RT, et al. Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology 1993;43:515-519.
6. Kokmen E, Chandra V, Schoenberg B. Trends in incidence of dementing illness in Rochester, Minnesota, in three quinquennial periods, 1960-1974. Neurology 1988;38:975-980.
7. Katzman R, Aronson M, Fuld P, et al. Development of demeriting illnesses in an 80-year-old volunteer cohort. Ann Neurol 1989;25:317-324.
8. Schoenberg BS, Kokmen E, Okazaki H. Alzheimer's disease and other dementing illnesses in a defined United States population: incidence rates and clinical features. Ann Neurol 1987;22:724-729.
9. Fitch N, Becker R, Heller A. The inheritance of Alzheimer's disease: a new interpretation. Ann Neurol 1988;23:14-19.
10. Hofman A, Schulte W, Tanja TA, et al. History of dementia and Parkinson's disease in 1st-degree relatives of patients with Alzheimer's disease. Neurology 1989;39:1589-1592.
11. Edwards JK, Larson EB, Hughes JP, Kukull WA. Are there clinical and epidemiological differences between familial and non-familial Alzheimer's disease? J Am Geriatr Soc 1991;39: 477-483.
12. Payami H, Montee K, Kaye J. Evidence for familial factors that protect against dementia and outweigh the effect of increasing age. Am J Hum Genet 1994;54:650-657.
13. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
14. Yu C-E, Payami H, Olson JM, et al. Apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer disease. Am J Hum Genet 1994;54:631-642.
15. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer disease in late onset families. Science 1993;261:921-923.
16. Payami H, Kaye J, Heston LL, Bird TD, Schellenberg GD. Apolipoprotein E genotypes and Alzheimer's disease. Lancet 1993;342:737-738.
17. van Duijn CM, Farrer LA, Cupples LA, Hayman A. Genetic transmission of Alzheimer's disease among families in a Dutch population based study. J Med Genet 1993;30:640-646.
18. Silverman JM, Rainford K, Fillenbaum G, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part VI. Family history assessment: a multicenter study of first-degree relatives of Alzheimer's disease probands and nondemented spouse controls. Neurology 1994;44:1253-1259.
19. Breitner JCS, Silverman JM, Mohs RC, Davis KL. Familial aggregation in Alzheimer's disease: comparison of risk among male and female relatives in successive generations. Neurology 1988;38:207-212.
20. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 1994;17:525-580.
21. Reilly SL, Ferrell RE, Sing CF. The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, MN. III. Correlations and covariances. Am J Hum Genet 1994; 55:1001-1018.
22. Payami H, Montee KR, Kaye JA, et al. Alzheimer's disease, apolipoprotein E4, and gender. JAMA 1994;271:1316-1317.
23. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
24. Kamino K, Orr HT, Payami H, et al. Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. Am J Hum Genet 1992;51:998-1014.
25. Schellenberg GD, Payami H, Wijsman EM, et al. Chromosome 14 and late-onset familial Alzheimer's disease. Am J Hum Genet 1994;53:619-628.
26. Phillips SM, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992;17:485-495.
27. Barrett-Conner E, Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. JAMA 1993; 269:2637-2641.
28. Robinson D, Friedman L, Marcus R, Tinklenberg J, Yesavage J. Estrogen replacement therapy and memory in older women. J Am Geriatr Soc 1994;42:919-922.
29. Brenner DE, Kukull WA, Stergachis A, et al. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population based case control study. Am J Epidemiol 1994;140:262-267.
30. Paganini-Hill A, Henderson V. Estrogen deficiency and risk of Alzheimer's disease. Am J Epidemiol 1994;140:256-261.